"We will strengthen our governance by setting up a "Stakeholder Committee", which will be the guardian of our commitment to positive finance, at the heart of our formalized raison d'être".
GENEO Capital Entrepreneur has completed the first chapter of its history. The team of the investment company evergreen, led by Fanny Letier and François Rivolier, has successfully raised €200 million. 200 million. "We achieved our objective in one year as hoped. Things accelerated at the beginning of the containment: we were at €160 million at the end of 2019 and our existing shareholders, joined by a few new ones, enabled us to reach €200 million in mid-April. While we were 300% mobilized among the companies invested, we saw in these families and entrepreneurs, with whom we further intensified communication in these very special weeks, a strong sign of encouragement to continue developing "entrepreneurial capital" and its long-term values, human capital, community spirit and positive impact", testify the co-founders.
What is the purpose of GENEO? Positive finance
Since its creation in March 2019, GENEO Capital Entrepreneur has completed seven transactions, all minority and in companies with a positive impact. These investments are now part of the GENEO "community", made up of its shareholders and experts. We are going to strengthen our governance by setting up a "stakeholders' committee", which will be the guardian of our commitment to positive finance, at the heart of the raison d'être that we have formalized," announce Fanny Letier and François Rivolier. We give a four-pronged definition. First, positive finance is that which is capable of withstanding economic cycles, hence our evergreen strategy. Second, it provides human capital in addition to financing, which is what our community and our platform of experts do. Third, it aims for a positive societal impact and, finally, positive finance is one that shares the wealth it creates with shareholders, managers, employees, territories... That's also why we created our endowment fund a few weeks ago. "The rest of GENEO's history will be written on this basis.
